T-cell receptor therapeutics are used to treat certain types of cancer, including prostate cancer and synovial sarcoma. These therapies work by modifying your T-cells, a type of white blood cell, to better recognize and attack cancer cells. T-cell receptor therapeutics are typically administered as intravenous infusions. An example of this type of medication is sipuleucel-T (Provenge).